======= ECHS1 ======= == Gene Information == * **Official Symbol**: ECHS1 * **Official Name**: enoyl-CoA hydratase, short chain 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1892|1892]] * **UniProt**: [[https://www.uniprot.org/uniprot/P30084|P30084]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ECHS1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ECHS1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602292|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene functions in the second step of the mitochondrial fatty acid beta-oxidation pathway. It catalyzes the hydration of 2-trans-enoyl-coenzyme A (CoA) intermediates to L-3-hydroxyacyl-CoAs. The gene product is a member of the hydratase/isomerase superfamily. It localizes to the mitochondrial matrix. Transcript variants utilizing alternative transcription initiation sites have been described in the literature. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Straight-chain enoyl-CoA thioesters from C4 up to at least C16 are processed, although with decreasing catalytic rate. Has high substrate specificity for crotonyl-CoA and moderate specificity for acryloyl-CoA, 3-methylcrotonyl-CoA and methacrylyl-CoA. It is noteworthy that binds tiglyl-CoA, but hydrates only a small amount of this substrate. {ECO:0000269|PubMed:26251176}. |ECH| |enoyl-CoA hydratase activity| |fatty acid beta-oxidation| |fatty acid oxidation| |lipid oxidation| |fatty acid catabolic process| |monocarboxylic acid catabolic process| |cellular lipid catabolic process| |lipid modification| |carboxylic acid catabolic process| |organic acid catabolic process| |lipid catabolic process| |fatty acid metabolic process| |mitochondrial matrix| |small molecule catabolic process| |monocarboxylic acid metabolic process| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |lipid metabolic process| |mitochondrion| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp241|QNZ 0.01μM R05 exp241]]|-2.23| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|-2.05| |[[:results:exp143|Phenformin 20μM R03 exp143]]|-2.04| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.85| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|-1.77| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|1.85| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.1| |[[:results:exp308|Rapamycin 2μM plus FK-506 5μM R07 exp308]]|2.13| |[[:results:exp274|Citral 50μM R06 exp274]]|2.95| |[[:results:exp432|YM155 0.001μM R08 exp432]]|3.09| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8927 * **Expression level (log2 read counts)**: 5.8 {{:chemogenomics:nalm6 dist.png?nolink |}}